PT-141 (Bremelanotide)
Libido restored at the source — not just the symptom.
PT-141, also known as Bremelanotide, is a melanocortin receptor agonist that addresses sexual dysfunction through the central nervous system — making it fundamentally different from PDE5 inhibitors like Viagra or Cialis, which work only on blood flow. PT-141 targets the root neurological drivers of sexual desire.
The Science
How It Works
PT-141 activates melanocortin receptors (MC3R and MC4R) in the hypothalamus — the brain region responsible for sexual arousal and desire. This triggers dopamine release and activates the neural pathways associated with libido, making it effective for both erectile dysfunction and low sexual desire in men.
What to Expect
Key Benefits
Enhanced Libido
Directly increases sexual desire at the neurological level — effective even when low libido is the primary complaint rather than mechanical dysfunction.
Improved Erectile Function
Works through a different mechanism than PDE5 inhibitors, making it effective for men who haven't responded to Viagra or Cialis.
Works Independently of Vascular Pathways
Because it acts centrally rather than on blood vessels, it can be used by men with cardiovascular conditions that contraindicate PDE5 inhibitors.
Psychological Component Addressed
By targeting the brain's arousal centers, PT-141 addresses the psychological and neurological aspects of sexual dysfunction — not just the physical.
Find out if PT-141 (Bremelanotide) is right for you.
A free 20-minute call with our physician team. No commitment required.
Who It's For
Men experiencing low libido, erectile dysfunction, or sexual dysfunction that hasn't responded to conventional treatments. Particularly valuable for men whose primary complaint is reduced desire rather than mechanical dysfunction.
Administration
Subcutaneous injection, typically administered 45–60 minutes before sexual activity. Some protocols use low-dose regular administration for sustained effect.
Safety Profile
Most common side effect is mild, transient nausea and flushing. PT-141 is FDA-approved (as Vyleesi) for hypoactive sexual desire disorder, giving it a well-established safety profile.
Ready to Start a PT-141 (Bremelanotide) Protocol?
Book a free consultation with our medical team. We'll review your labs and determine if PT-141 (Bremelanotide) is right for your goals.